Sign in

CIK 0001515673

  • Large accelerated filer

Ultragenyx Pharmaceutical Inc.

Sign in to watch
Ticker
RARE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
272546083
Phone
+1 415-483-8800
Business address
60 LEVERONI COURT, NOVATO, CA, 94949
  1. 4 Shares withheld for taxes EVP & Chief Commercial Officer gave up 260 shares (to pay taxes)
  2. 3 Insider Initial Statement of Ownership
  3. 4 Open-market sale EVP and General Counsel sold 2,715 shares at an average $62.33 ($169,221)
  4. 4 Grant or award EVP & Chief Commercial Officer acquired 3,500 shares (grant or award)
  5. 3 Insider Initial Statement of Ownership
  6. 4 Grant or award Director acquired 3,000 shares (grant or award)
  7. 4 Grant or award Director acquired 3,000 shares (grant or award)
  8. 4 Grant or award Director acquired 3,000 shares (grant or award)
  9. 4 Grant or award Director acquired 3,000 shares (grant or award)
  10. 4 Grant or award Director acquired 3,000 shares (grant or award)
  11. 4 Grant or award Director acquired 3,000 shares (grant or award)
  12. 4 Grant or award Director acquired 3,000 shares (grant or award)
  13. 4 Grant or award Director acquired 3,000 shares (grant or award)
  14. 4 Shares withheld for taxes President & CEO gave up 1,327 shares (to pay taxes)
  15. 4 Shares withheld for taxes CBO & EVP gave up 346 shares (to pay taxes)
  16. 4 Shares withheld for taxes Pinion John Richard gave up 260 shares (to pay taxes)
  17. 4 Shares withheld for taxes EVP & Chief Tech Ops Officer gave up 260 shares (to pay taxes)
  18. 4 Shares withheld for taxes CFO & Executive Vice President gave up 346 shares (to pay taxes)
  19. 4 Shares withheld for taxes VP, Controller and PAO gave up 433 shares (to pay taxes)
  20. 4 Shares withheld for taxes VP, Controller and PAO gave up 156 shares (to pay taxes)

Page 17 of 32 · 627 filings